CN116194431B - 萜酚化合物及其用途 - Google Patents

萜酚化合物及其用途

Info

Publication number
CN116194431B
CN116194431B CN202180038597.7A CN202180038597A CN116194431B CN 116194431 B CN116194431 B CN 116194431B CN 202180038597 A CN202180038597 A CN 202180038597A CN 116194431 B CN116194431 B CN 116194431B
Authority
CN
China
Prior art keywords
cbd
pet
compound
biphenyl
diol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202180038597.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN116194431A (zh
Inventor
C·G·斯托特
C·R·赫普
R·古鲁桑卡尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plant Therapy Co ltd
Alinova Biosciences Ltd
Original Assignee
Plant Therapy Co ltd
Alinova Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plant Therapy Co ltd, Alinova Biosciences Ltd filed Critical Plant Therapy Co ltd
Publication of CN116194431A publication Critical patent/CN116194431A/zh
Application granted granted Critical
Publication of CN116194431B publication Critical patent/CN116194431B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/32Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/003Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202180038597.7A 2020-03-31 2021-03-31 萜酚化合物及其用途 Active CN116194431B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003270P 2020-03-31 2020-03-31
US63/003,270 2020-03-31
PCT/GB2021/050812 WO2021198692A1 (en) 2020-03-31 2021-03-31 Terpenophenolic compounds and their use

Publications (2)

Publication Number Publication Date
CN116194431A CN116194431A (zh) 2023-05-30
CN116194431B true CN116194431B (zh) 2026-01-02

Family

ID=75426633

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180038597.7A Active CN116194431B (zh) 2020-03-31 2021-03-31 萜酚化合物及其用途

Country Status (12)

Country Link
US (2) US12552733B2 (https=)
EP (1) EP4126800A1 (https=)
JP (1) JP7714571B2 (https=)
KR (1) KR20230121960A (https=)
CN (1) CN116194431B (https=)
AU (1) AU2021248627A1 (https=)
BR (1) BR112022019616A2 (https=)
CA (1) CA3177186A1 (https=)
GB (2) GB2609814B (https=)
IL (1) IL296861A (https=)
MX (1) MX2022011832A (https=)
WO (1) WO2021198692A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3179235A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019046806A1 (en) * 2017-09-01 2019-03-07 Botaniteck Llc SYNTHETIC CANNABIDIOL COMPOSITIONS AND METHODS OF MAKING THE SAME
CN109939091A (zh) * 2015-06-16 2019-06-28 香港浸会大学 化合物在制备用于治疗结肠直肠癌的药物中的用途
WO2020041326A1 (en) * 2018-08-20 2020-02-27 Berkowitz Barry A Applications of known and novel cannabinoids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136839A (en) * 2000-06-16 2006-12-10 Yissum Res Dev Co Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
CA2623723A1 (en) 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
TWI583374B (zh) * 2010-03-30 2017-05-21 Gw伐瑪有限公司 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
WO2014177593A1 (en) 2013-04-29 2014-11-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Amorfrutin analogs as ppargamma-modulators
US9526706B1 (en) 2015-06-16 2016-12-27 Hong Kong Baptist University Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury
US10059683B2 (en) 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
AU2017250303B2 (en) 2016-04-15 2019-09-26 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
JP2019523228A (ja) 2016-06-16 2019-08-22 ティーウィノット テクノロジーズ リミテッド カンナビノイドプロドラッグの製造のための方法、薬学的製剤、およびその使用
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
CA3179235A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors
AU2020345656A1 (en) * 2019-09-09 2022-04-21 Kare Chemical Technologies Inc. Cannabinoid derivatives, precursors and uses
WO2021046640A1 (en) * 2019-09-10 2021-03-18 Kare Chemical Technologies Inc. Cannabinoid derivatives and precursors, and asymmetric synthesis for same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109939091A (zh) * 2015-06-16 2019-06-28 香港浸会大学 化合物在制备用于治疗结肠直肠癌的药物中的用途
WO2019046806A1 (en) * 2017-09-01 2019-03-07 Botaniteck Llc SYNTHETIC CANNABIDIOL COMPOSITIONS AND METHODS OF MAKING THE SAME
WO2020041326A1 (en) * 2018-08-20 2020-02-27 Berkowitz Barry A Applications of known and novel cannabinoids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Leslie W. Crombie等.Synthesis of bibenzyl cannabinoids hybrids of two biogenetic series found in Cannabis sativa.J. CHEM. SOC. PERKIN TRANS. I.1988,(第5期),第1265、1269页. *
Synthesis of bibenzyl cannabinoids hybrids of two biogenetic series found in Cannabis sativa;Leslie W. Crombie等;J. CHEM. SOC. PERKIN TRANS. I;19880101(第5期);第1265、1269页 *

Also Published As

Publication number Publication date
GB2595355A (en) 2021-11-24
GB202215746D0 (en) 2022-12-07
US20230227390A1 (en) 2023-07-20
BR112022019616A2 (pt) 2022-12-06
KR20230121960A (ko) 2023-08-22
MX2022011832A (es) 2023-03-03
WO2021198692A1 (en) 2021-10-07
JP7714571B2 (ja) 2025-07-29
GB2609814A (en) 2023-02-15
US12552733B2 (en) 2026-02-17
CA3177186A1 (en) 2021-10-07
US20230225985A1 (en) 2023-07-20
AU2021248627A1 (en) 2022-12-01
GB202104690D0 (en) 2021-05-12
IL296861A (en) 2022-11-01
EP4126800A1 (en) 2023-02-08
GB2609814B (en) 2024-08-28
JP2023520794A (ja) 2023-05-19
CN116194431A (zh) 2023-05-30

Similar Documents

Publication Publication Date Title
EP4262979B1 (en) Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
US20240238218A1 (en) Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof
US20240025858A1 (en) Cannabinoid derivatives as pharmaceutically active compounds and method of preparation thereof
EP3800177B1 (en) Fenfluramine compositions and methods of preparing the same
WO2012073375A1 (ja) 新規化合物、並びに、キネシンスピンドルタンパク質阻害剤及びその応用
TW200831510A (en) Compounds
TW201619133A (zh) 新穎亞氨腈(iminonitrile)衍生物
CN116194431B (zh) 萜酚化合物及其用途
KR20150036126A (ko) 포스포디에스테라아제 10 효소의 억제제
US5807897A (en) Aminotetralin derivative and compositions and method of use thereof
WO1995004028A1 (en) Indane and tetrahydronaphthalene derivatives as calcium channel antagonists
JP3857429B2 (ja) 含硫黄抗真菌剤
KR100435009B1 (ko) 방향족고리상의페닐치환체를갖는테트랄린및간질,발작및뇌또는척수외상의치료에서의그의용도
US6894053B2 (en) Serotonergic agents with long-acting in vivo effects
JP2021533115A (ja) 神経疾患またはミトコンドリア疾患の処置のための化合物
JP2025536577A (ja) イミダゾール化合物とそのナトリウムチャネル阻害剤としての使用
EP1366007A2 (en) Compounds with high monoamine transporter affinity
GB2628746A (en) Terpenophenolic compounds and their use
JP2021505594A (ja) 鎮痛化合物及びその製造方法
DD297401A5 (de) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronapthaline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
WO2017193986A1 (zh) 苯双酚衍生物及其制备方法和在医药上的应用
KR20190129070A (ko) 신규 벤즈이미다졸론 화합물 및 그의 의약 용도
CN106810532A (zh) 一类胺烷氧基噻吨酮类化合物、其制备方法和用途
JP3805901B2 (ja) 芳香族抗真菌剤
JP3805905B2 (ja) 芳香族抗真菌剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant